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Abstract	
Background:	




Twenty	 time	 series	 of	 8-hour	 postprandial	 periods	 (PP)	 for	 a	 same	 60g-carbohydrate	
meal	 were	 collected	 from	 a	 closed-loop	 controller	 validation	 study.	 A	 single	
concatenated	 time	 series	was	 produced	 representing	 a	 collection	 of	 data	 from	 similar	
scenarios,	 resulting	 in	 seasonality.	 Variability	 in	 the	 resulting	 time	 series	 was	
representative	 of	worst-case	 intra-subject	 variability.	 Following	 a	 leave-one-out	 cross-
validation,	 seasonal	 and	 non-seasonal	 autoregressive-integrated-moving-average	
models	(SARIMA	and	ARIMA)	were	built	to	analyze	the	effect	of	seasonality	in	the	model	




SARIMA	outperformed	ARIMA	revealing	a	 significant	 role	of	 seasonality.	For	 a	5-h	PH,	
average	MAPE	was	 reduced	 in	 26.62%.	 Considering	 individual	 runs,	 the	 improvement	
ranged	 from	6.3%	 to	54.52%.	 In	 the	 best-performing	 case	 this	 reduction	 amounted	 to	
29.45%.	The	benefit	of	seasonality	was	consistent	among	different	PHs,	although	lower	
PHs	benefited	more,	with	MAPE	reduction	over	50%	for	PHs	of	60	and	120	minutes,	and	
over	 40%	 for	 180	min.	 Consideration	 of	 insulin	 infusion	 rate	 into	 the	 seasonal	model	
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Introduction	
An	important	feature	of	any	artificial	pancreas1,2	 is	 its	ability	to	predict	glucose	along	a	
given	prediction	horizon	 (PH),	 either	 as	part	 of	 the	 control	 algorithm	 itself,	 such	 as	 in	
systems	 based	 on	 Model	 Predictive	 Control	 (MPC)	 techniques3-5,	 or	 as	 part	 of	 a	
monitoring	 subsystem	 to	 predict,	 for	 instance,	 hypoglycemic	 episodes6-8.	 Model	
requirements	and	 input	 information	will	depend	on	 the	specific	purpose.	For	 instance,	
future	 values	 of	 insulin	 infusion	 are	 available	 during	 the	 MPC	 optimization	 process	
where	 predictions	 are	 needed.	 However,	 this	 is	 not	 the	 case	 in	 the	 context	 of	 risk	
prediction	in	patient	monitoring	during	closed-loop	operation.	
	
Linear	 empirical	 dynamic	models	 rely	 on	 time	 series	 as	 an	 observation	 on	 a	 dynamic	
system9.	 These	 include	 autoregressive	 (AR),	 autoregressive-moving-average	 (ARMA),	








considering	 a	 30-min	 PH.	 A	 median	 RMSE	 ranging	 from	 18.33	 to	 20.32	 mg/dL,	
depending	on	the	selection	of	a	forgetting	factor,	was	reported	for	that	PH.	Low-order	AR	
and	ARMA	models	were	considered	by	Eren-Oruklu	and	associates12	considering	PHs	up	
to	 30	 minutes	 in	 healthy	 and	 type	 2	 diabetes	 subjects.	 A	 sum	 of	 squares	 of	 glucose	
prediction	error	 ranging	between	10.32	and	12.55	mg/dL	was	reported,	depending	on	
the	 study,	 for	 a	 30-min	 PH.	 Finan	 and	 colleagues13-15	 evaluated	 ARX	 models	 from	
simulated	 and	 clinical	 ambulatory	 data	 with	 5-min	 sampling	 time.	 The	 authors	
concluded	that	60	minutes	was	a	maximum	achievable	PH	in	terms	of	model	prediction	
accuracy.	An	average	RMSE	of	26,	34	and	40	mg/dL	was	reported	 for	30-,	45-	and	60-
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min	PH,	respectively15.	This	corresponds	to	an	improvement	of	9%	compared	to	a	zero-
order-hold	 predictor.	 A	 variety	 of	 linear	 and	 nonlinear	 time-series	 models	 were	
evaluated	 by	 Ståhl	 and	 Johansson16	 	 from	 clinical	 data	 from	 one	 subject,	 with	 non-
uniform	 and	 sparse	 sampling	 (fingerstick	measurements)	with	 spline	 interpolation,	 in	
order	to	produce	a	short-term	blood	glucose	predictors	for	up	to	two-hour-ahead	blood	






This	 paper	 explores	 the	 extension	 of	 the	 concept	 of	 seasonality	 for	 glucose	 prediction	
with	 a	 proof-of-concept	 study.	 The	main	 rationale	 is	 that	 pre-processing	 of	 CGM	 time	
series	 (and	 available	 additional	 information)	may	 translate	 daily	 events	 into	 seasonal	
phenomena.	 For	 instance,	 glucose	 concentration	 tends	 to	 peak	 and	 then	 decline	 in	 a	
characteristic	way	after	a	meal	 intake	 in	a	particular	 scenario.	 In	 this	 case,	 a	new	pre-
processed	family	of	time	series	can	be	built	from	the	original	CGM	data	by	concatenating	
postprandial	 periods	 (PPs)	 of	 fixed	 length	 where	 similarity	 of	 behaviors	 is	 expected,	
according	to	some	metrics,	which	would	theoretically	produce	seasonal	time	series.	This	
allows	 for	 the	 application	 of	 seasonal	 models	 that	 exploit	 this	 similarity	 for	 more	







CGM	 time	 series	 covering	 8-hour	 PPs	 for	 a	 same	meal	 were	 collected	 from	 the	 Clinic	
University	 Hospital	 of	 Valencia,	 Spain.	 Data	 belonged	 to	 a	 closed-loop	 controller	
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validation	study	where	10	T1D	subjects	underwent	an	 in-hospital	8-hour	standardized	
mixed	meal	 test	 (60g	carbohydrate)	on	 two	occasions	with	a	hybrid	artificial	pancreas	
with	 15-min	 sampling	 period.	 Patients	wore	 two	 pumps	with	 CGM	 devices	 (Paradigm	
Veo®	insulin	pump	with	Enlite-2	sensors®,	Medtronic	MiniMed,	Northridge,	CA),	which	
were	calibrated	15	minutes	before	the	meal	test	was	administered	(lunch	at	noon).	CGM	
glucose	 data	was	 available	 for	 eight	 hours	 after	 the	meal,	 from	12:00	p.m.	 until	 20:00	
p.m.	 Glucose	 concentration	 was	 also	 measured	 every	 15	 minutes	 with	 a	 reference	





Variance	of	 the	Area-Under-the-Curve	 for	 the	8-hour	duration	of	 the	study	(CV-AUC8h),	
which	was	 computed	with	 the	 trapezoidal	 rule.	 Euclidean	 distance	 among	 paired	 PPs	
was	also	computed	 to	determine	 time	series	 shape	similarity.	A	 sampling	period	of	15	






average	 (SMA)	 terms.	 In	 an	 empirical	 dynamic	 model,	 an	 observation	 at	 time	𝑡	is	
expressed	 as	 a	 linear	 combination	 of	 observations	 at	 times	 𝑡 − 1, 𝑡 − 2, … , 𝑡 − 𝑝	
(previous	𝑝	measurements)	 by	 the	 AR	 component,	 and	 as	 a	 linear	 combination	 of	
stochastic	 errors,	 also	 called	 shocks,	 at	 times	𝑡, 𝑡 − 1, 𝑡 − 2, … , 𝑡 − 𝑞 		 by	 the	 MA	
component.	In	a	SARIMA	model,	SAR	and	SMA	terms	are	added	so	that	an	observation	at	
time	𝑡	depends	 on	 previous	 observations	 and	 stochastic	 errors	 at	 times	with	 lags	 that	
are	 multiples	 of	 the	 seasonality	 period	𝑠.	 In	 the	 context	 of	 postprandial	 glucose	
prediction,	 this	 means	 that	 the	 glucose	 prediction	 will	 depend	 not	 only	 on	 previous	
measurements	for	that	PP,	but	also	on	previous	PPs	in	the	time	series.	
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Given	a	CGM	time	series	{𝐺 𝑡 	|	𝑡	 = 	1, 2, … , 𝑘},	a	SARIMA	model	is	expressed	as:	
															𝛻23	𝛻4𝐺 𝑡 = 𝑐 + 𝑤(𝑡),				 	 	 	 	 	 	 (1)	
															∅; 𝑧=> 𝛷@ 𝑧=2 𝑤(𝑡) = 𝜃B 𝑧=> 𝛩D 𝑧=2 𝜀 𝑡 ,							 	 	 	 (2)	
where	𝐺(𝑡)	is	 the	 glucose	 concentration	 at	 time	 t,	𝑐	is	 a	 constant	 term	 (intercept),	𝛻	is	
the	 backward	 difference	 operator,	 i.e.	𝛻𝐺 𝑡 ∶= 	𝐺(𝑡) − 	𝐺(𝑡 − 1),	𝑑	is	 the	 non-seasonal	
integration	order,	𝛻2	is	 the	seasonal	backward	difference	operator,	 i.e.	𝛻2𝐺 𝑡 ∶= 	𝐺(𝑡) −
	𝐺(𝑡 − 𝑠),	𝐷	is	 the	 seasonal	 integration	 order,	 the	 input	𝜀 𝑡 	is	 the	 stochastic	 error	
following	 a	 white	 noise	 process	 	𝜀 𝑡 	~	𝑊𝑁 0, 𝜎N 	and	∅; 𝑧=> ,	𝛷@ 𝑧=2 ,	𝜃B 𝑧=> 	and	
𝛩D 𝑧=2 	are	 polynomials	 in	 the	 lag	 (back-shift)	 operator	 	𝑧=>	of	 degree	𝑝,	𝑃,	𝑞	and	𝑄,	
respectively,	defined	as		
(AR)						∅; 𝑧=> ∶= 1 − ∅>𝑧=> − ∅N𝑧=N − ⋯− ∅;𝑧=;,	
(SAR)				𝛷@ 𝑧=2 ∶= 1 − 𝛷2𝑧=2 − 𝛷N2𝑧=N2 − ⋯− 𝛷@2𝑧=@2,	
(MA)						𝜃B 𝑧=> ∶= 1 + 𝜃>𝑧=> + 𝜃N𝑧=N + ⋯+ 𝜃B𝑧=B,	
(SMA)				𝛩D 𝑧=2 ∶= 1 + 𝛩2𝑧=2 + 𝛩N2𝑧=N2 + ⋯+ 𝛩D2𝑧=D2.	
Model	(1)-(2)	can	be	expressed	in	short	form	as	SARIMA 𝑝, 𝑑, 𝑞 𝑃, 𝐷, 𝑄 2.	
	
Exogenous	variables	
Exogenous	 variables	 in	 model	 (1)-(2)	 were	 also	 considered.	 There	 exist	 different	
approaches	 for	 incorporating	 exogenous	 variables	 into	 a	 model.	 Denoting	 as	𝑋(𝑡)	the	
exogenous	 variable,	 a	 term	𝜂U 𝑧=> 𝑋 𝑡 ,	 where	𝜂U 𝑧=> ≔ 𝜂W + 𝜂>𝑧=> + ⋯+ 𝜂U𝑧=U ,	 is	
commonly	 added	 to	 the	 right-hand-side	 of	 equation	 (2),	 yielding	 the	 so-called	 ARX,	
ARMAX,	ARIMAX	or	SARIMAX	models	depending	on	the	considered	structure.			In	many	
statistical	 packages	 such	 as	 R	 and	 Eviews,	 exogenous	 variables	 are	 considered	 as	
explanatory	variables	 into	a	 linear	regression	model	with	a	stochastic	error	process	of	
certain	structure.	In	this	case,	a	SARIMAX	model	is	expressed	as		
															𝛻23	𝛻4𝐺 𝑡 = 𝑐 + 𝜂U 𝑧=> 𝑋 𝑡 + 𝑤(𝑡)																																													 	 		(3)	
															∅@ 𝑧=> 𝛷@ 𝑧=2 𝑤 𝑡 = 	 	𝜃B 𝑧=> 𝛩D 𝑧=2 𝜀 𝑡 																															 																		(4)	
when	current	and	past	values	of	 the	exogenous	variable	𝑋(𝑡)	are	used.	 In	this	case,	 the	
polynomial	𝜂U 𝑧=> 	represents	 a	 finite-impulse-response	 filter.	The	 rest	of	 components	
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are	 defined	 as	 in	 (1)-(2).	 Model	 (3)-(4)	 can	 be	 expressed	 in	 short	 form	 as	
SARIMAX 𝑝, 𝑑, 𝑞, 𝑟 𝑃, 𝐷, 𝑄 2.	 Granger	 causality	 test18	 can	 be	 used	 to	 determine	 the	










available.	 	 PPs	 in	 the	 training	 set	 were	 randomly	 ordered	 at	 each	 run	 according	 to	 a	
random	sequence	generator	(www.random.org).	A	stationarity	analysis	was	first	carried	
out	with	 the	 unit-root	 test	 (Augmented	Dickey-Fuller	 test)20.	 The	 backward-difference	
operator	𝛻	was	applied	to	the	time	series	as	many	times	as	necessary	(integration	order	
𝑑)	 to	 remove	 non-stationarity,	 if	 present.	 Sample	 autocorrelation	 function	 (ACF)	 and	
partial	 autocorrelation	 function	 (PACF)	 were	 used	 to	 identify	 the	 orders	 of	 the	
autoregressive	and	moving	average	terms	(𝑝	and	𝑞,	respectively),	as	well	as	 identifying	
seasonality	 (seasonally	 differencing	 the	 time	 series	 with	 the	 operator	𝛻2	if	 necessary).	
Maximum	 likelihood	was	 used	 for	 parameter	 estimation.	 Akaike	 information	 criterion	
(AIC)	 was	 used	 for	 model	 selection,	 which	 is	 defined	 in	 Eviews	 software	 as	𝐴𝐼𝐶 ∶=
	>
\
(−2	𝐿	 + 	2𝐾),	 where	𝐿	is	 the	 value	 of	 the	 log-likelihood,	𝐾	is	 the	 number	 of	 free	
parameters	in	the	model	and	𝑛	is	the	number	of	observations.	Remark	the	scaling	by	1/
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	 Mean	absolute	error:	𝑀𝐴𝐸 ∶= 	 >
\
𝑒d\de> ,	
	 Root	mean	squared	error:	𝑅𝑀𝑆𝐸 ∶= 	 >
\
𝑒dN\de> ,	






where	𝑛	is	 again	 the	 number	 of	 observations,	𝐺d 	is	 the	𝑖-th	 observation,	𝐺d 	is	 a	 forecast	






peaks	 ranging	 from	 304	 mg/dL	 (P91)	 to	 125	 mg/dL	 (P42)	 and	 the	 incidence	 of	
hypoglycemia	 in	 some	 patients	 (P11,	 P51,	 P52,	 P71,	 P101),	 two	 of	 them	 severe	 (P11,	
P101),	according	 to	CGM	values.	 	They	were	non-normally	distributed.	 Inter-individual	
variability	measured	by	CV-AUC8h	was	21.52%,	whereas	intra-individual	variability	was	
9.17%.	However,	the	latter	spanned	from	3.22%	(patient	6)	to	18.67%	(patient	9).	Since	
only	 two	 studies	 per	 patient	 were	 available,	 intra-patient	 variability	 might	 be	





comparisons).	 P81,	 P82	 and	 P91	 were	 the	 most	 dissimilar	 with	 the	 rest	 of	 periods	
(higher	 incidence	 of	 yellow-red	 boxes).	 	 Total	 basal	 insulin	 infusion	 in	 the	 8-h	 period	
ranged	 from	 5.21U	 (P31)	 to	 16.40U	 (P71).	 An	 extended	 bolus	 computed	 from	 the	
patient’s	 insulin-to-carbohydrate	 ratio	 and	 open-loop	 basal	 infusion	 rate	 was	
additionally	administered	at	meal	time.	
	
Both	 SARIMA	 and	ARIMA	models	were	 identified	 for	 each	 run	 in	 the	 cross-validation.	
Figure	4(a)	shows	the	forecasting	accuracy	metrics	for	a	5-h	PH	for	both	cases.	A	high	PH	
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was	 initially	 chosen	 to	 challenge	 the	model.	 SARIMA	outperform	ARIMA	 in	 all	metrics	
(mean(SD):	MAE(mg/dL)	34.56(19.35)	vs.	47.72(24.43);	RMSE(mg/dL)	40.02(21.62)	vs.	
55.02(26.93);	 MAPE(%)	 22.02(9.41)	 vs.	 30.01(13.05);	 p<0.05	 in	 all	 cases).	 In	 the	
following,	the	analysis	will	be	restricted	to	MAPE	since	the	three	measures	provided	the	
same	 information.	 Figure	4(b)	 shows	 the	 obtained	MAPE	as	 the	PH	 increases	 from	30	
min	 to	 5	 hours,	 consistently	 outperforming	 SARIMA.	 The	 identified	 model	 structure	









Model	SARIMA 4, 0, 4 1, 0, 1 mm	was	the	most	appropriate	model,	with	AIC	7.9566.	Table	
1	 shows	 the	 estimated	 model	 parameters	 using	 maximum	 likelihood	 estimation.	 All	
spikes	 in	 the	 residuals	 ACF	were	within	 the	 significance	 limits	 (white	 noise).	 Table	 2	
shows	 the	 Ljung-Box	 Q	 test	 for	 testing	 randomness	 at	 each	 distinct	 lag,	 also	
demonstrating	 that	 the	 residuals	 have	 no	 remaining	 autocorrelations.	 The	 tests	 for	
residual	 normality	 showed	 that	 the	 residuals	were	 approximately	normal.	 	 A	MAPE	of	
6.73%	was	 obtained	 for	 training	data.	 	 A	 similar	 fitting	was	 obtained	 for	ARIMA,	with	
MAPE	7.05%.		Figure	5	shows	the	prediction	performance	using	validation	data	for	a	5-h	




The	 effect	 of	 considering	 insulin	 infusion	 as	 exogenous	 variable	 for	 performance	
improvement	 was	 investigated.	 Besides,	 insulin	 infusion	 information	 is	 needed	 in	
applications	 such	 as	 MPC.	 This	 analysis	 was	 carried	 out	 only	 for	 Run	 4	 as	 the	 best	
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performing	 case,	 challenging	 further	 improvement.	 Insulin	 infusion	 signal	 contained	
bolus	and	basal	infusion	and	was	expressed	in	U	per	sampling	period.	Granger	causality	
test	was	applied	 to	 test	 the	null	hypothesis	 that	CGM	does	not	 “Granger	cause”	 insulin	
infusion	 and	 vice	 versa.	 The	null	 hypothesis	was	 rejected	with	 a	 significant	 p-value	 of	
0.0146.	 Therefore,	 inclusion	 of	 insulin	 infusion	 into	 the	 model	 might	 improve	
performance.	 The	 order	 of	 the	 exogenous	 polynomial	 was	 computed	 from	 the	 cross-
correlation	 plot	 and	 AIC,	 resulting	 in	 the	model	 SARIMAX 4, 0, 4, 2 1, 0, 1 mm	with	 AIC	
7.9544.	 Table	 3	 shows	 the	 estimated	 parameters	 for	 this	model.	 The	 same	 procedure	
was	 used	 to	 derive	 its	 non-seasonal	 counterpart	 resulting	 in	 the	 model	
ARIMAX 4, 0, 4, 2 	with	AIC	7.9952.	 	 In	 the	 forecasting	period,	 a	MAPE	of	 5.12%	and	 a	
RMSE	of	8.47	mg/dL	were	obtained	for	the	SARIMAX	model	 for	a	5-h	PH,	compared	to	
6.62%	 and	 10.28	 mg/dL	 for	 SARIMA,	 and	 10.51%	 and	 16.17	 mg/dL	 for	 ARIMAX.	
Differences	among	the	behavior	of	the	different	models	can	be	observed	in	Figure	5.		
	









be	much	more	 challenging	 than	nocturnal	 period	 for	 an	 artificial	 pancreas23.	 Both	 CV-
AUC8h	 and	 Euclidean	 distance	 (Fig.	 3)	 showed	 large	 inter-individual	 variability	 and	 a	
large	 range	 in	 intra-individual	 variability,	 with	 its	 worst-case	 represented	 by	 inter-
individual	variability.	Thus,	the	concatenated	time	series	defines	a	challenging	scenario	
with	a	worst-case	highly	variable	patient.	Data	variability	might	be	attenuated	with	the	
use	 of	 classification	 techniques,	 collecting	 similar	 enough	 postprandial	 responses	 into	
different	datasets,	with	their	corresponding	prediction	model.		
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A	first-order	seasonal	AR	and	MA	component	was	identified	with	seasonality	lag	33	in	all	
SARIMA	 runs	 due	 to	 the	 concatenated	 nature	 of	 the	 time	 series.	 In	 all	 runs,	 SARIMA	
outperformed	ARIMA	revealing	a	significant	role	of	seasonality.	 	5-h	PH	average	MAPE	
was	 reduced	 in	 26.62%.	 Considering	 individual	 runs,	 the	 improvement	 ranged	 from	
6.3%	(Run	7;	validation	data	P41)	 to	54.52%	(Run	3;	validation	data	P21).	 In	 the	best	
performing	 case,	 according	 to	 MAPE	 (Run	 4),	 this	 reduction	 amounted	 to	 29.45%.	
Prediction	improvement	by	introducing	seasonality	also	becomes	apparent	from	Figure	
5.	 The	 benefit	 of	 seasonality	 was	 consistent	 among	 different	 prediction	 horizons,	 as	






Consideration	 of	 insulin	 infusion	 rate	 into	 the	 seasonal	 model	 further	 improved	
performance	 for	 Run	 4.	 Although	 analysis	 was	 limited	 to	 this	 case	 to	 reduce	
computational	 burden,	 remark	 it	 corresponds	 to	 the	 most	 challenging	 situation	 for	
model	improvement	since	SARIMA	model	for	Run	4	has	the	best	prediction	accuracy	in	
the	 cross-validation	 study.	 SARIMAX	 improved	 performance	 as	 compared	 to	 SARIMA	
with	 a	 61.89%	 reduction	 in	 MAPE	 (2.90%	 vs.	 7.61%)	 for	 30-min	 PH	 to	 a	 7.33%	
reduction	at	2-h	PH	(5.86%	vs.	5.46%)	and	reductions	over	20%	for	PHs	over	180	min,	
as	shown	in	Table	4.	A	RMSE	below	10	mg/dL	was	obtained	for	all	PHs.	This	means	that	




This	 is	 a	 proof-of-concept	 study	 and	 as	 such	 it	 has	 limitations.	 It	 is	 assumed	 that	
mealtime	is	known,	allowing	for	the	construction	of	concatenated	time	series	with	fixed-
length	PPs.	However,	 to	date,	meal	announcement	 is	a	common	component	of	artificial	
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pancreas	 systems	 and,	 otherwise,	 meal	 detection	 algorithms	 are	 incorporated24-26.	
Remark	that	although	focus	was	put	on	PPs,	this	approach	can	be	applied	to	other	fixed-
length	time	series	data	subsets	representing	characteristic	scenarios	where	similarity	is	
expected	or	 learned	from	classification	techniques.	Another	 limitation	 is	 the	data	used,	
which	 did	 not	 correspond	 to	 a	 single	 patient,	 although	 inter-patient	 variability	 in	 the	
data	 was	 representative	 of	 worst-case	 intra-patient	 variability	 defining	 a	 challenging	
scenario.	 A	 collection	 of	 18	 PPs	were	 used	 for	model	 training	 at	 each	 cross-validation	
run.	 Seasonal	 components	 of	 the	 identified	models	 were	 first	 or	 second	 order,	 which	
means	that	current	meal	depends,	at	most,	on	the	two	previous	similar	meals.	Thus,	the	
length	 of	 the	 data	 used	 is	 considered	 appropriate	 for	 this	 proof-of-concept	 study.		





improve	 model	 predictive	 power	 allowing	 for	 the	 significant	 extension	 of	 prediction	
horizons.	Further	work	 is	now	needed	 for	 the	classification	of	periods	under	scenarios	
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p-value t-Statistic Std.	Error Value Parameter 
0.0000 9.117968 14.70842 134.1109 𝒄 
0.0000 349.7433 0.008934 3.124690 ∅> 
0.0000 -242.5068 0.015602 -3.783549 ∅N 
0.0000	134.7894	0.015166	2.044158	∅m	
0.0000	-48.98071	0.008156	-0.399508	∅q	
0.0000 16.03866 0.056899 0.912586 𝛷mm 




0.0000 -10.56878 0.078243 -0.826937 𝛩mm 











48 36 24 12 Lag 
30.513 21.358 10.575 2.8661 Q-Stat 













Prob. t-	Statistic	Std.Error Coefficient Variable 
0.0000 7.492023 17.53808 131.3957 𝒄 
0.0006 3.448056 0.307175 1.059158 𝜂W 
0.0135 2.478004 0.376779 0.933659 𝜂> 
0.4979	0.678182	0.323739	0.223623	𝜂N	
0.0000 528.1297 0.006145 3.245163 ∅> 
0.0000 -515.5566 0.007966 -4.107178 ∅N 
0.0000	206.9404	0.011389	2.356905	∅m	
0.0000	-61.48038	0.008237	-0.50644	∅q	
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Fig.	 2.	 CGM	 time	 series	 resulting	 from	 the	 concatenation	 of	 twenty	 8-h	 postprandial	
periods	 for	 a	 same	 60g	 carbohydrate	 meal.	 The	 notation	 Pij	 is	 used	 to	 name	 the	
different	 periods,	 where	 i	 is	 the	 number	 of	 the	 patient,	𝑖 ∈ 1, … ,10 ,	 and	 j	 is	 the	
number	of	 the	study	per	patient,	𝑗 ∈ 1,2 .	Sampling	period	 is	15	minutes,	yielding	33	
samples	per	postprandial	period.		
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Fig.	 3.	 Similarity	 among	postprandial	periods	 in	 the	CGM	 time	 series	 as	measured	by	







































Fig.	 4.	 Forecasting	 performance:	 (a)	 Mean	 and	 standard	 deviation	 of	 forecasting	
measures	for	the	20-fold	cross-validation	and	a	5-h	PH:	MAE(mg/dL)	is	Mean	Absolute	
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